Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway

Oncogene

Volumn 19, Issue 24, 2000, Pages 2812-2819

  Honda, Kei ^a,b   Mihara, Hirotsugu ^a   Kato, Yuzo ^a   Yamaguchi, Akio ^b   Tanaka, Hirofumi ^c   Yasuda, Hideyo ^c   Furukawa, Koichi ^a   Urano, Takeshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Anaphase promoting complex; Aurora2; Degradation; Ubiquitin proteasome pathway

Indexed keywords

PROTEASOME; PROTEASOME INHIBITOR; PROTEIN AURORA2; PROTEIN KINASE; UBIQUITIN; UNCLASSIFIED DRUG;

ANAPHASE; ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; COMPETITIVE INHIBITION; COMPLEX FORMATION; ENZYME DEGRADATION; EUKARYOTIC CELL; HUMAN; HUMAN CELL; MAMMAL CELL; METAPHASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; SEQUENCE HOMOLOGY;

ANIMALIA; EUKARYOTA; MAMMALIA;

EID: 0034213929     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203609     Document Type: Article

References (30)

1. Amon A, Irniger S and Nasmyth K. (1994). Cell, 77, 1037-1050.
2. Biggins S, Severin FF, Bhalla N, Sassoon I, Hyman AA and Murray AW. (1999). Genes Dev., 13, 532-544.
3. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ and Plowman GD. (1998). EMBO J., 17, 3052-3065.
4. Bischoff JR and Plowman GD. (1999). Trends Cell Biol., 9, 454-459.
5. Campanero MR and Flemington EK. (1997). Proc. Natl. Acad. Sci. USA, 94, 2221-2226.
6. Ciechanover A. (1994). Cell, 79, 13-21.
7. Ciechanover A. (1998). EMBO J., 17, 7151-7160.
8. Fang G, Yu H and Kirschner MW. (1998). Mol. Cell., 2, 163-171.
9. Fenteany G and Schreiber SL. (1998). J. Biol. Chem., 273, 8545-8548.
10. Francisco L, Wang W and Chan CS. (1994). Mol. Cell. Biol., 14, 4731-4740.
11. Glotzer M, Murray AW and Kirschner MW. (1991). Nature, 349, 132-138.
12. Glover DM, Leibowitz MH, McLean DA and Parry H. (1995). Cell, 81, 95-105.
13. Gopalan G, Chan CS and Donovan PJ. (1997). J. Cell. Biol., 138, 643-656.
14. Honda R and Yasuda H. (1999). EMBO J., 18, 22-27.
15. Kimura M, Kotani S, Hattori T, Sumi N, Yoshioka T, Todokoro K and Okano Y. (1997). J. Biol. Chem., 272, 13766-13771.
16. Koepp DM, Harper JW and Elledge SJ. (1999). Cell, 97, 431-434.
17. Maki CG, Huibregtse JM and Howley PM. (1996). Cancer Res., 56, 2649-2654.
18. Murray AW, Solomon MJ and Kirschner MW. (1989). Nature, 339, 280-286.
19. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF and Rolfe M. (1995). Science, 269, 682-685.
20. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D and Goldberg AL. (1994). Cell, 78, 761-771.
21. Salghetti SE, Kim SY and Tansey WP. (1999). EMBO J., 18, 717-726.
22. Shindo M, Nakano H, Kuroyanagi H, Shirasawa T, Mihara M, Gilbert DJ, Jenkins NA, Copeland NG, Yagita H and Okumura K. (1998). Biochem. Biophys. Res. Commun., 244, 285-292.
23. Stewart E, Kobayashi H, Harrison D and Hunt T. (1994). EMBO J., 13, 584-594.
24. Townsley FM, Aristarkhov A, Beck S, Hershko A and Ruderman JV. (1997). Proc. Natl. Acad. Sci. USA, 94, 2362-2367.
25. Treier M, Staszewski LM and Bohmann D. (1994). Cell, 78, 787-798.
26. Urano T, Emkey R and Feig LA. (1996). EMBO J., 15, 810-816.
27. Urano T, Furukawa K and Shiku H. (1993). Oncogene, 8, 1371-1376.
28. Varshavsky A. (1997). Trends Biochem. Sci., 22, 383-387.
29. Yanai A, Arama E, Kilfin G and Motro B. (1997). Oncogene, 14, 2493-2950.
30. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR and Sen S. (1998). Nat. Genet., 20, 189-193.